Table 3.
Response rate to immunomodulators and anti-tumor necrosis factor for severe or refractory microscopic colitis
Number of patients | Mean age (yr) | Treatment | Duration of therapy | Response rate | |
Münch et al[22], 2013 | 46 | 59 | Azathioprine or 6-MP 2 mg/kg per day | Variable, 1-57 mo | 41% |
Pardi et al[30], 2001 | 9 | 62 | Azathioprine or 6-MP 2 mg/kg per day | 26 mo | 56% |
Münch et al[21], 2013 | 9 | 62 | Methotrexate 15-25 mg/wk | 12 wk | 0% |
Esteve et al[25], 2011 | 4 | 59 | Infliximab 5 mg/kg at 0, 2, 6 wk then every 6-8 wk intravenously | Variable, 5-14 mo | 75% |
Münch et al[26], 2012 | 3 | 55 | Adalimumab induction1 then 40 mg subcutaneously every 2 wk | 6 wk | 66% |
Pola et al[24], 2013 | 1 | 58 | Infliximab 5 mg/kg at 0, 2, 6 wk then every 8 wk intravenously | 6 mo | 100% |
Adalimumab induction: 160 mg (week 0), 80 mg (week 2), and 40 mg (week 4).